N/A
Manufactured by Chartwell Governmental & Specialty RX, LLC.
25,712 FDA adverse event reports analyzed
Last updated: 2026-04-14
PHENOBARBITAL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chartwell Governmental & Specialty RX, LLC.. The most commonly reported adverse reactions for PHENOBARBITAL include DRUG INEFFECTIVE, SEIZURE, OFF LABEL USE, DRUG INTERACTION, TOXICITY TO VARIOUS AGENTS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHENOBARBITAL.
Out of 13,995 classified reports for PHENOBARBITAL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 25,712 FDA FAERS reports that mention PHENOBARBITAL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, SEIZURE, OFF LABEL USE, DRUG INTERACTION, TOXICITY TO VARIOUS AGENTS, STATUS EPILEPTICUS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Chartwell Governmental & Specialty RX, LLC. in connection with PHENOBARBITAL. Always verify the specific product and NDC with your pharmacist.